Finemost Corporation

Form 483 issued July 26, 2018 · Cerritos, California

Inspection
Jul 24 – Jul 26, 2018
Investigator
Bryan A. Galvez
Observations
1
Pages
2
FEI number
3003253809

In short: On July 26, 2018, FDA issued a Form 483 with 1 observation to Finemost Corporation in Cerritos, California (FEI 3003253809) after an inspection that ran Jul 24 – Jul 26, 2018. The investigator was Bryan A. Galvez. Most observations concern laboratory controls; the most-cited regulation is 21 CFR 211.165 (testing and release for distribution).

At a glance

1 of 1 observations on this 483 concern laboratory controls.

Laboratory controls1

Most cited: 21 CFR 211.165(a) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Testing and release of drug product for distribution do not include appropriate laboratory determination of satisfactory…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Finemost Corporation?

FDA listed 1 observation on this Form 483, mostly about laboratory controls. The most-cited regulation is 21 CFR 211.165 (testing and release for distribution). The opening words of each observation are shown on this page.

Who inspected Finemost Corporation?

Bryan A. Galvez is named on this Form 483, for the inspection of Jul 24 – Jul 26, 2018. Each investigator has a profile showing what they cite most.

When was Finemost Corporation inspected by FDA?

The inspection ran Jul 24 – Jul 26, 2018, and the Form 483 is dated July 26, 2018.

How do I get the full Form 483 for Finemost Corporation?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free